Literature DB >> 3092125

Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes.

O M Larsson, L Gram, I Schousboe, A Schousboe.   

Abstract

A preferential effect of valproate on gamma-aminobutyric acid (GABA) in the nerve terminal compartment has been proposed. Gamma-vinyl GABA, an irreversible inhibitor of GABA-transaminase (GABA-T) causes a preferential increase in the GABA compartment of the non-nerve terminal. The aim of the present study was to investigate further this apparent differential effect on GABA-T of these compounds in neurones and glia. The investigations were undertaken in neurones and astrocytes, cultured separately. After incubation with valproate, the IC50 value for astrocytes was found to be 1202 microM of valproate and for neurones 634 microM. Assuming regional differences of concentrations of valproate in the brain, the observed IC50 values might be clinically relevant. Culturing the cells in the presence of gamma-vinyl GABA demonstrated IC50 values for astrocytes and neurones of 89 and 24 microM, respectively. The (S)isomer of gamma-vinyl GABA was the most active inhibitor of GABA-T in both glia and neurones. After withdrawal of gamma-vinyl GABA from the culture media of the cells, in neurones 50% of the activity of GABA-T was regained within 2-4 days. In astrocytes a similar time course was observed. These findings are in agreement with clinical data: the IC50 values correspond to clinically-relevant serum levels of gamma-vinyl GABA in humans only the (S)isomer showed an antiepileptic effect in animal models of epilepsy a delayed antiepileptic effect, after withdrawal of gamma-vinyl GABA, has been established in clinical studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092125     DOI: 10.1016/0028-3908(86)90214-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  14 in total

Review 1.  Targeting inhibitory neurotransmission in tinnitus.

Authors:  Ben D Richardson; Thomas J Brozoski; Lynne L Ling; Donald M Caspary
Journal:  Brain Res       Date:  2012-02-14       Impact factor: 3.252

2.  Kinetic characterization of GABA-transaminase from cultured neurons and astrocytes.

Authors:  O M Larsson; A Schousboe
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

3.  Behavioral and genotoxic evaluation of rosmarinic and caffeic acid in acute seizure models induced by pentylenetetrazole and pilocarpine in mice.

Authors:  Vanessa Rodrigues Coelho; Caroline Gonçalves Vieira; Luana Pereira de Souza; Lucas Lima da Silva; Pricila Pflüger; Gabriela Gregory Regner; Débora Kuck Mausolff Papke; Jaqueline Nascimento Picada; Patrícia Pereira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-30       Impact factor: 3.000

Review 4.  Potential of levetiracetam in mood disorders: a preliminary review.

Authors:  Anjana Muralidharan; Zubin Bhagwagar
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Transport of valproate and its effects on GABA uptake in astroglial primary culture.

Authors:  M Nilsson; E Hansson; L Rönnbäck
Journal:  Neurochem Res       Date:  1990-08       Impact factor: 3.996

Review 6.  Clinical pharmacology of vigabatrin.

Authors:  P J Schechter
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

7.  Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures.

Authors:  M Nilsson; E Hansson; L Rönnbäck
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

8.  Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes.

Authors:  A Schousboe; O M Larsson; N Seiler
Journal:  Neurochem Res       Date:  1986-11       Impact factor: 3.996

Review 9.  Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.

Authors:  W Löscher
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

Review 10.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.